The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Objectives
To examine whether prostate‐specific antigen doubling time (PSADT) correlates with metastases, all‐cause mortality (ACM), and prostate cancer‐specific mortality (PCSM) and to identify PSADT thresholds that can be used clinically for risk stratification in men with M0 castration‐resistant prostate cancer (CRPC).
Materials and Methods
We collected data on 441 men with M0 CRPC in 2000–2015...
Introduction
Prostate cancer is a heterogeneous disease, and risk stratification systems have been proposed to guide treatment decisions. However, significant heterogeneity remains for those with unfavorable‐risk disease.
Methods
This study included 3335 patients undergoing radical prostatectomy without adjuvant radiotherapy in the SEARCH database. High‐risk patients were dichotomized into standard...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.